Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA adds fresh ‘breakthrough’ for Novartis’ cancer combo Tafinlar and Mekinist
FDA adds fresh ‘breakthrough’ for Novartis’ cancer combo Tafinlar and Mekinist
FDA adds fresh ‘breakthrough’ for Novartis’ cancer combo Tafinlar and Mekinist
Submitted by
admin
on October 23, 2017 - 9:57am
Source:
Endpoints
News Tags:
FDA
Novartis
Tafinlar
Mekinist
non-small cell lung cancer
Headline:
FDA adds fresh ‘breakthrough’ for Novartis’ cancer combo Tafinlar and Mekinist
Do Not Allow Advertisers to Use My Personal information
